Pharmamar
Clinical trials sponsored by Pharmamar, explained in plain language.
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is an early-stage study testing a new intravenous cancer drug called PM54 in patients with advanced solid tumors that have progressed after standard treatments. The main goals are to find the safest dose, understand how the body processes the drug, and look for early signs t…
Phase: PHASE1 • Sponsor: PharmaMar • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major cancer trial tests promising new combo against aggressive sarcoma
Disease control Recruiting nowThis large Phase 3 study is testing whether adding a newer drug called lurbinectedin to the standard chemotherapy doxorubicin works better for controlling metastatic leiomyosarcoma, a rare and aggressive muscle tissue cancer. The trial will enroll 450 adults who haven't had previ…
Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC